NCT01196897View on ClinicalTrials.gov

Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE)

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

September 30, 2012

Study Completion Date

November 30, 2013

Conditions
Atrial Fibrillation
Interventions
DEVICE

WATCHMAN LAA Closure Technology (Gen 4.0)

Implantation of the WATCHMAN device into the left atrial appendage.

Trial Locations (3)

60389

Sankt Katharinen Hospital / Cardiovasculares Centrum, Frankfurt

93049

Krankenhaus der Barmherzige Bruder, Regensburg

150 30

NA Homolce Hospital, Prague

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY